Finished product reference
Loratadine
Tablet, Orally Disintegrating · Oral · 10 mg
- List code
- 52298
Indications
USE(S) temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, water eyes itching of the nose or throat
Dosage and administration (summary)
DIRECTIONS adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
Warnings and precautions
WARNINGS DO NOT USE if you have ever had an allergic reaction to this product or any of its ingredients
Storage and supply
STORAGE store between 20º to 25ºC (68º to 77ºF)
Source: Loratadine (Loratadine) — US FDA prescribing information, 2025-06-13, DailyMed. Summarised and shortened; the full label governs. Iranian registration, indications and labelling may differ.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.